OTCMKTS:EROX Human Pheromone Sciences (EROX) Stock Price, News & Analysis $0.0004 0.00 (0.00%) As of 09/26/2022 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Human Pheromone Sciences Stock (OTCMKTS:EROX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get EROX alerts:Sign Up Key Stats Today's Range$0.0004▼$0.000450-Day Range N/A52-Week Range$0.00▼$0.13VolumeN/AAverage Volume13,574 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Human Pheromone Sciences, Inc. engages in the research, development, manufacture, and marketing of consumer products containing synthetic human pheromones and other mood enhancing compounds in the United States and internationally. It provides a line of fragrance and toiletry products for men and women under the Natural Attraction trademark. The company also licenses its initial compounds and related technology, as well as sells its patented compounds to licensed customers to include these compounds as components in their products. In addition, it offers private label manufacturing services to licensed customers. Human Pheromone Sciences, Inc. distributes its products through distributors, as well as through the Web site, naturalattraction.com. The company was formerly known as EROX Corporation and changed its name to Human Pheromone Sciences, Inc. in May 1998. Human Pheromone Sciences, Inc. was founded in 1989 and is headquartered in San Jose, California. Read More Receive EROX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Human Pheromone Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address EROX Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com EROX Stock Analysis - Frequently Asked Questions How have EROX shares performed this year? Human Pheromone Sciences' stock was trading at $0.0004 on January 1st, 2025. Since then, EROX shares have increased by 0.0% and is now trading at $0.0004. How do I buy shares of Human Pheromone Sciences? Shares of EROX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today8/24/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Staples Industry Toilet Preparations Sub-IndustryN/A Current SymbolOTCMKTS:EROX CIKN/A Webwww.naturalattraction.com Phone(408) 938-3030Fax408-938-3025Employees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta3.30 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (OTCMKTS:EROX) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Human Pheromone Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Human Pheromone Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.